Project description
Making the most of health information for an optimal patient experience
The digitisation of healthcare information has infinite benefits for clinicians, patients and their support network. When it comes to patient engagement, digital information tools can facilitate patients’ journey by offering them access to actionable, understandable, relevant, reliable and evidence-based information that meets their specific needs, health context and literacy level. The EU-funded Gravitate-Health project aims to demonstrate how an integrated, digital, user-centric health information solution could enable tangible improvements in the availability and understanding of health information from a set of trusted sources. Moreover, Gravitate-Health will highlight how improved availability and understanding of health information can lead to better adherence to treatment, safer use of medication and improved health outcomes, and overall health-related quality of life.
Objective
The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life. It is our vision that engagement of citizens in their own health can only be achieved with access to actionable, understandable, relevant, reliable and evidence-based information meets their specific needs, health context, and literacy level. This project's ambition is to provide a key piece to advance this vision: the Gravitate Lens (G-lens), which focuses (but does not conceal or filter) approved electronic product information (ePI) content, and offers a route for patients to access trustworthy, up-to-date information that better meet their individual needs.
Gravitate-Health is an integrated digital health information project. The principle objective is to demonstrate how use of an integrated, digital, user-centric health information solution with two-way communication could enable tangible improvements in availability and understanding of health information from a set of trusted sources, starting with regulator-approved medicinal product information (e.g. package leaflet content) and EHR-IPS (International Patient Summary). The secondary objectives are to demonstrate that the improved availability and understanding of health information from trusted sources translate to higher levels of adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life, and to develop new and deeper insights into how use of available health information can be optimized to act as effective risk minimization measures.
The project allows for efficient and timely development of the G-lens, provides testing grounds for new services and an evaluation framework to test the efficiency, efficacy and safety of Gravitate-Health services. Our main outputs will be an open source digital platform supporting G-Lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization.
The Gravitate-Health is a public – private partnership with 41 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.
Fields of science
Keywords
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
0313 Oslo
Norway
See on map
Participants (43)
CT13 9NJ Sandwich
See on map
1000 Bruxelles / Brussel
See on map
00138 Roma
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28040 Madrid
See on map
53111 Bonn
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
BRUSSELS Brussels / Bruxelles
See on map
9860 OOSTERZELE
See on map
10557 Berlin
See on map
9019 Tromso
See on map
D02 CX56 DUBLIN 2
See on map
1478 Lorenskog
See on map
0154 Oslo
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
D02H364 DUBLIN
See on map
11524 ATHINA
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
17177 Stockholm
See on map
20123 Milano
See on map
1050 189 Lisboa
See on map
0213 Oslo
See on map
1050 Bruxelles / Brussel
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
1050 Bruxelles / Brussel
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participation ended
08035 Barcelona
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1165 Kobenhavn
See on map
Participation ended
111 44 Stockholm
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28046 MADRID
See on map
28022 Madrid
See on map
3531AH Utrecht
See on map
11316 Tallinn
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
8000 AARHUS C
See on map
02105 Boston Ma
See on map
151 85 Sodertaelje
See on map
51373 Leverkusen
See on map
52078 Aachen
See on map
RG21 4FA Basingstoke
See on map
W6 7AP London
See on map
013 Dublin
See on map
4056 Basel
See on map
4070 Basel
See on map
1070 Bruxelles / Brussel
See on map
KT22 7TW Leatherhead Surrey
See on map
08018 Barcelona
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4 Dublin
See on map
0450 Oslo
See on map
2340 Beerse
See on map